Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00816257 · ClinicalTrials.gov registry record
Lung Transplant Specimen Repository and Data Registry Protocol
A clinical trial of Lung Transplantation, sponsored by Karen Wood.
- Completed
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT00816257 is a study of Lung Transplantation that has completed, run by Karen Wood. The registered enrollment target is 64 participants, below the 331-participant average among 12 other Lung Transplantation trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00816257, a study of Lung Transplantation, has completed, sponsored by Karen Wood.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
All patients enrolled in the registry will be recipients of single and double lung transplantation (bilateral sequential, heart-lung, or living related donor grafts). During the routine management of lung recipients frequent surveillance of the lung allograft is necessary. This routinely involves: measurement of pulmonary functions, chest radiography, collection of peripheral blood to assess other organ function and monitor therapeutic drug levels, and bronchoscopic evaluation allowing for collection of lung lavage fluid and lung tissue biopsy. This surveillance normally follows a set schedule during the first one to two years following the transplant procedure. Surveillance is routinely performed at weeks 2, 8, 12, 24, 36, and 52 during the first year following the transplant procedure. Additional surveillance may be performed at any time when clinically indicated for the optimal management of the recipient. Information and specimens collected from each of these encounters will be entered in the data registry and specimen repository.
Conditions Studied
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2005-11 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00816257
The ClinicalTrials.gov registry entry for NCT00816257 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 331-participant average among 12 other Lung Transplantation trials with a reported enrollment target (81% lower). The listed sponsor is Karen Wood, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Transplantation appearing as the primary indexed condition, and to 0 interventions.
NCT00816257 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00816257 about?
NCT00816257 is a clinical study titled "Lung Transplant Specimen Repository and Data Registry Protocol". All patients enrolled in the registry will be recipients of single and double lung transplantation (bilateral sequential, heart-lung, or living related donor grafts). During the routine management of lung recipients frequent surveillance of the lung allograft is necessary. This routinely involves: m...
What is the current status of trial NCT00816257?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2005-11. Estimated completion is 2013-11.
What conditions does trial NCT00816257 study?
This clinical trial studies the following conditions: Lung Transplantation.
Who is sponsoring clinical trial NCT00816257?
This trial is sponsored by Karen Wood, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00816257 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation
RECRUITING
-
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
RECRUITING · Phase 2
-
Trifecta-Lung cfDNA-MMDx Study
RECRUITING
-
Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
RECRUITING
-
Transplanting Lungs From Uncontrolled Donation After Circulatory Death
RECRUITING · NA
-
This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.